Assesment of PTCH1 promoter methylation in BCC carcinogenesis

Cilt: 19 Sayı: 2 5 Aralık 2014
PDF İndir
EN

Assesment of PTCH1 promoter methylation in BCC carcinogenesis

Abstract

Basal Cell Carcinoma (BCC) is the most common cancer in humans. It is known that PTCH1 mutations in Sonic Hedgehog pathway play significant role in BCC  pathogenesis. However  PTCH1 (Patched) inactivation through promoter methylation is still under investigation. In this study promoter methylation of the PTCH1 gene was analysed by Combined Bisulphite Restriction Analysis in 10 formalin-fixed paraffin-embedded (FFPE) BCC tissues. There was no methylation in any of the samples. Results suggest that PTCH1 promoter methylation is not effective in BCC carcinogenesis and FFPE tissues are not suitable for methylation analysis since 44 specimens were included in the study and only 10 of them gave result.

Keywords

Kaynakça

  1. Lacour JP. Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms. Br J Dermatol 2002; 146: 17-19.
  2. Toyota M, Kopecky KJ, Toyota MO, et al. Methylation profiling in acute myeloid leukemia. Blood 2001; 97: 2823-2829.
  3. Cretnik M, Musani V, Oreskovic S, Leovic D, Levanat S. The Patched gene is epigenetically regulated in ovarian dermoids and fibromas, but not in basocellular carcinomas. Int J Mol Med 2007; 19: 875-883.
  4. Pan S, Dong Q, Sun LS, Li TJ. Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modification of the two-hit hypothesis. Clin Cancer Res 2010; 16: 442-450. Heitzer E, Bambach I, Dandachi N, Horn M, Wolf P. PTCH promoter methylation at low level in sporadic basal cell carcinoma analysed by three different approaches. Exp Dermatol 2010; 19: 926-928.

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yayımlanma Tarihi

5 Aralık 2014

Gönderilme Tarihi

15 Nisan 2013

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2014 Cilt: 19 Sayı: 2

Kaynak Göster

APA
Sayın Kocakap, D. (2014). Assesment of PTCH1 promoter methylation in BCC carcinogenesis. EASTERN JOURNAL OF MEDICINE, 19(2), 105-106. https://izlik.org/JA25BS97UJ
AMA
1.Sayın Kocakap D. Assesment of PTCH1 promoter methylation in BCC carcinogenesis. EASTERN JOURNAL OF MEDICINE. 2014;19(2):105-106. https://izlik.org/JA25BS97UJ
Chicago
Sayın Kocakap, Derya. 2014. “Assesment of PTCH1 promoter methylation in BCC carcinogenesis”. EASTERN JOURNAL OF MEDICINE 19 (2): 105-6. https://izlik.org/JA25BS97UJ.
EndNote
Sayın Kocakap D (01 Aralık 2014) Assesment of PTCH1 promoter methylation in BCC carcinogenesis. EASTERN JOURNAL OF MEDICINE 19 2 105–106.
IEEE
[1]D. Sayın Kocakap, “Assesment of PTCH1 promoter methylation in BCC carcinogenesis”, EASTERN JOURNAL OF MEDICINE, c. 19, sy 2, ss. 105–106, Ara. 2014, [çevrimiçi]. Erişim adresi: https://izlik.org/JA25BS97UJ
ISNAD
Sayın Kocakap, Derya. “Assesment of PTCH1 promoter methylation in BCC carcinogenesis”. EASTERN JOURNAL OF MEDICINE 19/2 (01 Aralık 2014): 105-106. https://izlik.org/JA25BS97UJ.
JAMA
1.Sayın Kocakap D. Assesment of PTCH1 promoter methylation in BCC carcinogenesis. EASTERN JOURNAL OF MEDICINE. 2014;19:105–106.
MLA
Sayın Kocakap, Derya. “Assesment of PTCH1 promoter methylation in BCC carcinogenesis”. EASTERN JOURNAL OF MEDICINE, c. 19, sy 2, Aralık 2014, ss. 105-6, https://izlik.org/JA25BS97UJ.
Vancouver
1.Derya Sayın Kocakap. Assesment of PTCH1 promoter methylation in BCC carcinogenesis. EASTERN JOURNAL OF MEDICINE [Internet]. 01 Aralık 2014;19(2):105-6. Erişim adresi: https://izlik.org/JA25BS97UJ